3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder (PTSD) in adults

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effectiveness and safety of MDMA-assisted psychotherapy in treating adults with PTSD.

This is a protocol.

Health topics:

Published:

6 July 2022

Authors:

Žuljević MF, Vidak M, Vukojević J, Hren D, Poklepovic Pericic T

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Žuljević MF, Vidak M, Vukojević J, Hren D, Poklepovic Pericic T. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder (PTSD) in adults (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 7. Art. No.: CD015345. DOI: 10.1002/14651858.CD015345.